According to our understanding, one possibility of the therapy strategies for treating the severe cases of COVID-19 might be stimulation of β-AR on the innate immune cells via binding noradrenaline neurotransmitters and blockage of α1-adrenergic receptors via its antagonists. This evidence concerns the gene ADRB2 and COVID-19.